144 related articles for article (PubMed ID: 17130156)
21. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway.
Xu W; Tamura T; Takatsu K
Int Immunopharmacol; 2008 Feb; 8(2):351-61. PubMed ID: 18182251
[TBL] [Abstract][Full Text] [Related]
22. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
23. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung.
Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T
Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622
[TBL] [Abstract][Full Text] [Related]
24. Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.
Wilson KD; Raney SG; Sekirov L; Chikh G; deJong SD; Cullis PR; Tam YK
Int Immunopharmacol; 2007 Aug; 7(8):1064-75. PubMed ID: 17570323
[TBL] [Abstract][Full Text] [Related]
25. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
Fonseca DE; Kline JN
Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
[TBL] [Abstract][Full Text] [Related]
26. Thermolytic properties of 3-(2-pyridyl)-1-propyl and 2-[N-methyl-N-(2-pyridyl)]aminoethyl phosphate/thiophosphate protecting groups in solid-phase synthesis of oligodeoxyribonucleotides.
Cieślak J; Beaucage SL
J Org Chem; 2003 Dec; 68(26):10123-9. PubMed ID: 14682709
[TBL] [Abstract][Full Text] [Related]
27. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
28. In vivo priming heterophil innate immune functions and increasing resistance to Salmonella enteritidis infection in neonatal chickens by immune stimulatory CpG oligodeoxynucleotides.
He H; Genovese KJ; Swaggerty CL; Nisbet DJ; Kogut MH
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):275-83. PubMed ID: 17434210
[TBL] [Abstract][Full Text] [Related]
29. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells.
Wattrang E
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):218-28. PubMed ID: 19447503
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo.
Zhang L; Zhang M; Li J; Cao T; Tian X; Zhou F
Res Vet Sci; 2008 Dec; 85(3):495-502. PubMed ID: 18359498
[TBL] [Abstract][Full Text] [Related]
31. The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome.
Jaafari MR; Badiee A; Khamesipour A; Samiei A; Soroush D; Kheiri MT; Barkhordari F; McMaster WR; Mahboudi F
Vaccine; 2007 Aug; 25(32):6107-17. PubMed ID: 17629372
[TBL] [Abstract][Full Text] [Related]
32. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
Yu D; Putta MR; Bhagat L; Li Y; Zhu F; Wang D; Tang JX; Kandimalla ER; Agrawal S
J Med Chem; 2007 Dec; 50(25):6411-8. PubMed ID: 17988082
[TBL] [Abstract][Full Text] [Related]
33. Immunostimulatory sequences in immunotherapy.
Blanks DA
Curr Opin Otolaryngol Head Neck Surg; 2007 Aug; 15(4):281-5. PubMed ID: 17620904
[TBL] [Abstract][Full Text] [Related]
34. CpG-ODN increases resistance of olive flounder (Paralichthys olivaceus) against Philasterides dicentrarchi (Ciliophora: Scuticociliatia) infection.
Lee EH; Kim KH
Fish Shellfish Immunol; 2009 Jan; 26(1):29-32. PubMed ID: 18992348
[TBL] [Abstract][Full Text] [Related]
35. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
[TBL] [Abstract][Full Text] [Related]
36. Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken.
Wang Y; Shan C; Ming S; Liu Y; Du Y; Jiang G
Res Vet Sci; 2009 Jun; 86(3):399-405. PubMed ID: 18977008
[TBL] [Abstract][Full Text] [Related]
37. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mähler M; Hedrich HJ; Fichtner-Feigl S; Schölmerich J; Falk W; Hofmann C; Obermeier F
Gastroenterology; 2009 Jan; 136(1):278-87. PubMed ID: 18952084
[TBL] [Abstract][Full Text] [Related]
38. Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN.
Kim YS; Kim Y; Lee KJ; Kwon HJ; Kim DS; Kim TY
Int Arch Allergy Immunol; 2007; 144(4):315-24. PubMed ID: 17671391
[TBL] [Abstract][Full Text] [Related]
39. CpG-ODN enhances mammary gland defense during mastitis induced by Escherichia coli infection in goats.
Zhu YM; Miao JF; Zhang YS; Li Z; Zou SX; Deng YE
Vet Immunol Immunopathol; 2007 Dec; 120(3-4):168-76. PubMed ID: 17869348
[TBL] [Abstract][Full Text] [Related]
40. CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.
Thacker SG; McWilliams IL; Bonnet B; Halie L; Beaucage S; Rachuri S; Dey R; Duncan R; Modabber F; Robinson S; Bilbe G; Arana B; Verthelyi D
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008050. PubMed ID: 32109251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
